| 1 |
Tantray I, Ojha R, Sharma AP. Non-coding RNA and autophagy: Finding novel ways to improve the diagnostic management of bladder cancer. Front Genet 2022;13:1051762. [PMID: 36685879 DOI: 10.3389/fgene.2022.1051762] [Reference Citation Analysis]
|
| 2 |
Li K, Yao T, Wang Z. lncRNA-mediated ceRNA network in bladder cancer. Noncoding RNA Res 2023;8:135-45. [PMID: 36605618 DOI: 10.1016/j.ncrna.2022.12.002] [Reference Citation Analysis]
|
| 3 |
Mokhtarinejad M, Pirhoushiaran MP, Hesami S, Mehrabi S, Shirkoohi R, Lotfi M, Farahani AS. Investigating the expression of LNCRNAs TMPO-AS1, DDX11-AS1, and POLE gene in head and neck squamous cell carcinoma.. [DOI: 10.21203/rs.3.rs-2224676/v1] [Reference Citation Analysis]
|
| 4 |
Wu P, Guo Y, Liao Z. Susceptibility Loci in SLC15A1, UGT1A3, and CWC27 Genes Associated with Bladder Cancer in the Northeast Chinese Population. BioMed Research International 2022;2022:1-7. [DOI: 10.1155/2022/2988159] [Reference Citation Analysis]
|
| 5 |
Wang SS, Zhai GQ, Chen G, Huang ZG, Zhang Y, Zhang LJ, Dang YW, Li SH, Yan HB. Metadherin Promotes the Development of Bladder Cancer by Enhancing Cell Division. Cancer Biother Radiopharm 2022. [PMID: 35704039 DOI: 10.1089/cbr.2021.0392] [Reference Citation Analysis]
|
| 6 |
Kong F, Ma L, Wang X, You H, Zheng K, Tang R. Regulation of epithelial-mesenchymal transition by protein lysine acetylation. Cell Commun Signal 2022;20:57. [PMID: 35484625 DOI: 10.1186/s12964-022-00870-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Gao X, Cai J. Genome-wide Exploration of a Pyroptosis-Related Long Non-Coding RNA Signature Associated With the Prognosis and Immune Response in Patients With Bladder Cancer. Front Genet 2022;13:865204. [DOI: 10.3389/fgene.2022.865204] [Reference Citation Analysis]
|
| 8 |
Huang CS, Tsai CH, Yu CP, Wu YS, Yee MF, Ho JY, Yu DS. Long Noncoding RNA LINC02470 Sponges MicroRNA-143-3p and Enhances SMAD3-Mediated Epithelial-to-Mesenchymal Transition to Promote the Aggressive Properties of Bladder Cancer. Cancers (Basel) 2022;14:968. [PMID: 35205713 DOI: 10.3390/cancers14040968] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
